Author results

1XCG
  • Download 1xcg
  • View 1xcg
Molmil generated image of 1xcg
CRYSTAL STRUCTURE OF HUMAN RHOA IN COMPLEX WITH DH/PH FRAGMENT OF PDZRHOGEF
Descriptor:Rho guanine nucleotide exchange factor 11, Transforming protein RhoA
Authors:Derewenda, U., Oleksy, A., Stevenson, A.S., Korczynska, J., Dauter, Z., Somlyo, A.P., Otlewski, J., Somlyo, A.V., Derewenda, Z.S.
Deposit date:2004-09-01
Release date:2004-12-14
Last modified:2011-07-13
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle
Structure, 12, 2004
3O0E
  • Download 3o0e
  • View 3o0e
Molmil generated image of 3o0e
CRYSTAL STRUCTURE OF OMPF IN COMPLEX WITH COLICIN PEPTIDE OBS1
Descriptor:Outer membrane porin 1a (Ia;b;F), Colicin-E9, B-OCTYLGLUCOSIDE
Authors:Wojdyla, J.A., Housden, N.G., Korczynska, J., Grishkovskaya, I., Kirkpatrick, N., Brzozowski, A.M., Kleanthous, C.
Deposit date:2010-07-19
Release date:2010-12-08
Last modified:2011-07-13
Method:X-RAY DIFFRACTION (3.014 Å)
Cite:Directed epitope delivery across the Escherichia coli outer membrane through the porin OmpF.
Proc.Natl.Acad.Sci.USA, 107, 2010
5FV1
  • Download 5fv1
  • View 5fv1
Molmil generated image of 5fv1
CRYSTAL STRUCTURE OF HVEGF IN COMPLEX WITH VK DOMAIN ANTIBODY
Descriptor:VK DOMAIN ANTIBODY, VASCULAR ENDOTHELIAL GROWTH FACTOR A
Authors:Chung, C., Walker, A.
Deposit date:2016-02-02
Release date:2016-02-17
Last modified:2019-05-15
Method:X-RAY DIFFRACTION (2.7 Å)
Cite:Novel Interaction Mechanism of a Domain Antibody Based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency Than Ranibizumab and Bevacizumab and Improved Capacity Over Aflibercept.
J.Biol.Chem., 291, 2016
5FV2
  • Download 5fv2
  • View 5fv2
Molmil generated image of 5fv2
CRYSTAL STRUCTURE OF HVEGF IN COMPLEX WITH VH DOMAIN ANTIBODY
Descriptor:VH DOMAIN ANTIBODY, VASCULAR ENDOTHELIAL GROWTH FACTOR
Authors:Chung, C., Batuwangala, T.
Deposit date:2016-02-02
Release date:2016-02-17
Last modified:2019-05-15
Method:X-RAY DIFFRACTION (3.45 Å)
Cite:Novel Interaction Mechanism of a Domain Antibody Based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency Than Ranibizumab and Bevacizumab and Improved Capacity Over Aflibercept.
J.Biol.Chem., 291, 2016
6QM7
  • Download 6qm7
  • View 6qm7
Molmil generated image of 6qm7
LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT COMPLEXED WITH GSK3494245
Descriptor:Proteasome alpha1 chain, Proteasome alpha2 chain, Proteasome alpha3 chain, ...
Authors:Rowland, P., Goswami, P.
Deposit date:2019-02-01
Release date:2019-04-17
Last modified:2019-05-22
Method:ELECTRON MICROSCOPY (2.8 Å)
Cite:Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Proc.Natl.Acad.Sci.USA, 116, 2019
6QM8
  • Download 6qm8
  • View 6qm8
Molmil generated image of 6qm8
LEISHMANIA TARENTOLAE PROTEASOME 20S SUBUNIT APO STRUCTURE
Descriptor:Proteasome alpha1 chain, Proteasome alpha2 chain, Proteasome alpha3 chain, ...
Authors:Rowland, P., Goswami, P.
Deposit date:2019-02-01
Release date:2019-04-17
Last modified:2019-05-22
Method:ELECTRON MICROSCOPY (3.3 Å)
Cite:Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Proc.Natl.Acad.Sci.USA, 116, 2019